Publication:
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Simple item page
dc.contributor.coauthorŞenocak Taşçı, Elif
dc.contributor.coauthorOyan, Başak
dc.contributor.coauthorSönmez, Özlem
dc.contributor.coauthorMutlu, Arda Ulaş
dc.contributor.coauthorAtcı, Muhammed Mustafa
dc.contributor.coauthorSakin, Abdullah
dc.contributor.coauthorÖner, İrem
dc.contributor.coauthorYeşil Çınkır, Havva
dc.contributor.coauthorKarakurt Eryılmaz, Melek
dc.contributor.coauthorÇağlayan, Dilek
dc.contributor.coauthorBalçık, Onur Yazdan
dc.contributor.coauthorPaksoy, Nail
dc.contributor.coauthorKarabulut, Senem
dc.contributor.coauthorKıvrak Salim, Derya
dc.contributor.coauthorBilir, Cemil
dc.contributor.coauthorÖzen, Miraç
dc.contributor.coauthorÖzçelik, Melike
dc.contributor.coauthorArıcan, Ali
dc.contributor.coauthorAkagündüz, Baran
dc.contributor.coauthorİnal, Ali
dc.contributor.coauthorAydın, Dinçer
dc.contributor.coauthorÖzer, Leyla
dc.contributor.coauthorGülmez, Ahmet
dc.contributor.coauthorTurhal, Nazım Serdar
dc.contributor.coauthorAktürk Esen, Selin
dc.contributor.coauthorAlgın, Efnan
dc.contributor.coauthorİriağaç, Yakup
dc.contributor.coauthorŞakalar, Teoman
dc.contributor.coauthorÜnal, Çağlar
dc.contributor.coauthorEr, Özlem
dc.contributor.coauthorSeçmeler, Şaban
dc.contributor.coauthorBozkurt, Mustafa
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.facultymemberNo
dc.contributor.kuauthorAkbaş, Sinem
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2024-12-29T09:36:39Z
dc.date.issued2024
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessgold, Green Published
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionN/A
dc.identifier.doi10.1186/s12885-024-11863-0
dc.identifier.eissn1471-2407
dc.identifier.embargoN/A
dc.identifier.issue1
dc.identifier.pubmed38262962
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85182828807
dc.identifier.urihttps://doi.org/10.1186/s12885-024-11863-0
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22114
dc.identifier.volume24
dc.identifier.wos001148300200002
dc.keywordsMetastatic colorectal cancer
dc.keywordsRegorafenib
dc.keywords5-fluorouracil
dc.keywordsRechallenge chemotherapy
dc.keywordsThird-line treatment
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofBMC Cancer
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectMedical oncology
dc.subjectChemotherapy
dc.subjectMetastatic colorectal cancer
dc.subjectRegorafenib
dc.subject5-fluorouracil
dc.titleCorrection: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer
dc.typeOther
dspace.entity.typePublication
local.contributor.kuauthorAkbaş, Sinem
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext